These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Disclosure of the genetic risk of Alzheimer's disease. Gordon SC; Landa D N Engl J Med; 2010 Jan; 362(2):181-2; author reply 182. PubMed ID: 20071713 [No Abstract] [Full Text] [Related]
8. [Epidemiology of Alzheimer's disease]. Berr C Servir; 1999; 47(2):95-9. PubMed ID: 12035166 [No Abstract] [Full Text] [Related]
9. A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease. Saltini G; Dominici R; Lovati C; Cattaneo M; Michelini S; Malferrari G; Caprera A; Milanesi L; Finazzi D; Bertora P; Scarpini E; Galimberti D; Venturelli E; Musicco M; Adorni F; Mariani C; Biunno I Neurosci Lett; 2006 May; 398(1-2):53-8. PubMed ID: 16412574 [TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of Alzheimer's disease. Carter J; Anderton B Br J Hosp Med; 1994 May 18-31; 51(10):522-8. PubMed ID: 7921490 [TBL] [Abstract][Full Text] [Related]
11. 4 new genes identified as raising Alzheimer's disease risk. A multi-center research project unveils more targets to study for potential future treatment. Duke Med Health News; 2011 Jun; 17(6):4-5. PubMed ID: 21710700 [No Abstract] [Full Text] [Related]
15. Alzheimer's in the family. Lemonick MD Time; 2003 Dec; 162(22):86-7. PubMed ID: 14666605 [No Abstract] [Full Text] [Related]
16. No association of spastic paraparesis genes in PSEN1 Alzheimer's disease with spastic paraparesis. Karlstrom H; Kwok JB; Gregory GC; Hallupp M; Brooks WS; Schofield PR Neuroreport; 2007 Aug; 18(12):1267-9. PubMed ID: 17632280 [TBL] [Abstract][Full Text] [Related]
17. What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review. Ringman JM J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):228-33. PubMed ID: 16306245 [TBL] [Abstract][Full Text] [Related]
18. Effect of genetic testing for risk of Alzheimer's disease. Kane RA; Kane RL N Engl J Med; 2009 Jul; 361(3):298-9. PubMed ID: 19605835 [No Abstract] [Full Text] [Related]
19. Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies. Chiappelli M; Tumini E; Porcellini E; Licastro F Expert Rev Neurother; 2006 Sep; 6(9):1327-36. PubMed ID: 17009920 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease. Poirier J Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S91-7. PubMed ID: 18632009 [No Abstract] [Full Text] [Related] [Next] [New Search]